Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Setback for Alvogen in approval bid for IBS generic
Generics
District court denies Norwich’s motion to compel FDA to grant approval for its version of popular IBS medication | Court also grants summary judgment in favour of FDA and Norwich’s competitor.   2 November 2023
Spinal implant inventor sues over four ‘infringed’ products
Biotech
RSB Spine files patent infringement lawsuit against competitors over spinal implant products | Plaintiff claims the defendants had knowledge of patent infringement.   31 October 2023
Womble Bond Dickinson hires patent team
Americas
Biopharmaceutical patent partner leads team of technical advisors and an associate in California | Partner experienced in patent prosecution, freedom-to-operate analysis, and assessing infringement validity in the pharma and biotech industry.   26 October 2023
Pharma
International Trade Commission is to investigate 11 online pharmacies after Eli Lilly files trademark infringement complaint | The company accuses pharmacies of selling “low-grade” versions of its Mounjaro diabetes medicine.   24 October 2023
Biotech
Amy Baker Mandragouras’ (pictured) team follow her from Cooley | New counsel’s scientific expertise is “second-to-none” | Team has experience in strategic counselling and biotech patent portfolios.   19 October 2023
Americas
The firm's newest life sciences partners are patent litigators in biotech and pharma fields | Duo have secured Hatch-Waxman litigation victories.   19 October 2023
Pharma
Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.   12 October 2023
article
New addition brings multi-jurisdiction experience in life sciences and healthcare industries | Significant growth in patent litigation due to complex life sciences disputes and telecom and technology litigation.   12 October 2023
Pharma
Genexa files lawsuit against KinderFarms relating to agave-based over-the-counter pain relief medicines for children | Accuses KinderFarm of ‘willful, intentional, and deliberate’ actions.   5 October 2023
Pharma
Teva’s patents protecting migraine drug ruled invalid | Lilly’s motion for a new trial denied | ‘The court does not reach this decision nor overturn a jury verdict lightly’ says Judge Alison Burroughs.   28 September 2023

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.